ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
1074
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease Psychosis
Interventions
DRUG:
ACP-204
DRUG:
Placebo
Sponsor
ACADIA Pharmaceuticals Inc.